Can sleep disruption impair antiviral immune function?

Sleep is a biologically relevant modulator of antiviral immunity. The evidence supports transient impairment of selected immune functions after sleep loss, while the proposed effect on latent-virus control remains mechanistically credible but not directly established in humans.

Clinical and immune-function evidence

• Acute sleep loss reduces NK-cell function. In an experimental study of 23 healthy men, nighttime awakening reduced mean natural-killer (NK)-cell lytic activity to 72% of baseline; activity recovered after a subsequent recovery night. NK cells contribute to early antiviral defense, although this laboratory change does not by itself establish a higher clinical infection risk.
• Vaccine-response data are directionally consistent. Controlled influenza-vaccination studies found weaker early antibody responses after partial or total sleep deprivation. A meta-analysis associated objectively measured sleep <6 hours with lower antiviral-vaccine antibody responses, whereas self-reported short sleep was not significantly associated.
• Findings should not be assumed to apply equally to all sleep problems. In a rhinovirus challenge study, shorter sleep duration—but not habitual fragmentation—was associated with susceptibility. Vaccine-response findings in older adults and in obstructive sleep apnea are mixed.

Mechanistic relevance to latent viruses

• NK cells and cytotoxic T cells help restrain latent Epstein–Barr virus (EBV). In humanized-mouse EBV models, depletion of these cells increases viral burden and/or tumorigenesis.
• Sleep restriction may also alter antigen-specific CD4 T-cell responses and interferon-γ production, providing a coherent pathway by which disrupted sleep could increase the immune effort required to maintain viral latency.

Clinical implications

• For a 74-year-old, preserving adequate, regular sleep is a reasonable supportive measure for immune health, particularly around vaccination or acute illness. However, sleep disruption should not be interpreted as proven to cause EBV or cytomegalovirus reactivation.

Bottom line

• Sleep loss can transiently weaken antiviral immune responses, especially NK-cell activity and vaccine antibody responses; its contribution to latent-virus control is plausible but remains unproven in direct human studies.